Neue Therapien der Hyperpigmentierung am Horizont?

[1]  H. Moghimi,et al.  The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial , 2020, Journal of cosmetic dermatology.

[2]  Hesham A. Nada,et al.  Efficacy and tolerability of using platelet‐rich plasma versus chemical peeling in periorbital hyperpigmentation , 2019, Journal of cosmetic dermatology.

[3]  F. Iraji,et al.  Efficacy of mesotherapy with tranexamic acid and ascorbic acid with and without glutathione in treatment of melasma: A split face comparative trial , 2019, Journal of cosmetic dermatology.

[4]  S. Verma,et al.  Role of broad‐spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma , 2019, Journal of cosmetic dermatology.

[5]  L. Kolbe,et al.  Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. , 2019, The Journal of investigative dermatology.

[6]  S. Molina,et al.  Drug-Induced Hyperpigmentation: Review and Case Series , 2019, The Journal of the American Board of Family Medicine.

[7]  A. Firooz,et al.  Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin , 2019, Clinical, cosmetic and investigational dermatology.

[8]  J. Na,et al.  Melasma: Updates and perspectives , 2019, Experimental dermatology.

[9]  W. H. Merchán,et al.  Platelet‐rich plasma, a powerful tool in dermatology , 2019, Journal of tissue engineering and regenerative medicine.

[10]  Che-Hsin Lee,et al.  Effect of Sucrier Banana Peel Extracts on Inhibition of Melanogenesis through the ERK Signaling Pathway , 2019, International journal of medical sciences.

[11]  G. Nasif,et al.  Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. , 2019 .

[12]  A. Filoni,et al.  Melasma: How hormones can modulate skin pigmentation , 2019, Journal of cosmetic dermatology.

[13]  E. Pekmezci.  A novel triple combination in treatment of melasma: Significant outcome with far less actives , 2019, Journal of cosmetic dermatology.

[14]  S. Guterres,et al.  Azelaic acid-loaded nanoemulsion with hyaluronic acid – a new strategy to treat hyperpigmentary skin disorders , 2019, Drug development and industrial pharmacy.

[15]  M. Hussein,et al.  Platelet-rich plasma is a useful therapeutic option in melasma , 2018, The Journal of dermatological treatment.

[16]  P. Grimes,et al.  New oral and topical approaches for the treatment of melasma , 2018, International journal of women's dermatology.

[17]  M. Heckman,et al.  Evaluating the Efficacy, Safety, and Tolerability of the Combination of Tazarotene, Azelaic Acid, Tacrolimus, and Zinc Oxide for the Treatment of Melasma: A Pilot Study. , 2019, The Journal of clinical and aesthetic dermatology.

[18]  R. Dabas,et al.  A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma , 2019, Journal of cutaneous and aesthetic surgery.

[19]  Yun Li,et al.  Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study , 2019, European Journal of Dermatology.

[20]  D. Steiner,et al.  Evaluation of oral tranexamic acid in the treatment of melasma , 2018, Journal of cosmetic dermatology.

[21]  Y. Boo,et al.  Human skin‐depigmenting effects of resveratryl triglycolate, a hybrid compound of resveratrol and glycolic acid , 2018, International journal of cosmetic science.

[22]  R. Halder,et al.  Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review. , 2018, The Journal of clinical and aesthetic dermatology.

[23]  S. Dayal,et al.  Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life , 2017, Journal of cosmetic dermatology.

[24]  T. Vogt,et al.  [Melasma : An update on the clinical picture, treatment, and prevention]. , 2017, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[25]  E. Pierzchała,et al.  Comparison of efficacy of products containing azelaic acid in melasma treatment , 2016, Journal of cosmetic dermatology.

[26]  R. Dummer,et al.  A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[27]  C. Bayerl.  Behandlung von Hyperpigmentierungen , 2015, ästhetische dermatologie & kosmetologie.

[28]  T. Padhi,et al.  Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial , 2015, Indian journal of dermatology.

[29]  H. Sadeghi-Bazargani,et al.  The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial , 2015, Drug design, development and therapy.

[30]  P. Mansouri,et al.  Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial , 2015, The British journal of dermatology.

[31]  W. Roberts,et al.  Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation ‑ is there a case to be made? , 2015, Journal of drugs in dermatology : JDD.

[32]  Y. Boo,et al.  A study of the human skin-whitening effects of resveratryl triacetate , 2015, Archives of Dermatological Research.

[33]  Z. Draelos.  A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. , 2015, Journal of the American Academy of Dermatology.

[34]  E. Çalışkan,et al.  Regression of Melasma with Platelet-Rich Plasma Treatment , 2014, Annals of dermatology.

[35]  A. Pandya,et al.  Treatment of Melasma with Topical Agents, Peels and Lasers: An Evidence-Based Review , 2013, American Journal of Clinical Dermatology.

[36]  N. Virmani,et al.  Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety , 2013, Indian journal of dermatology.

[37]  R. Bhat,et al.  A Comparative Study of the Efficacy of 4% Hydroquinone vs 0.75% Kojic Acid Cream in the Treatment of Facial Melasma , 2013, Indian journal of dermatology.

[38]  P. Jain,et al.  Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation. , 2013, Journal of drugs in dermatology : JDD.

[39]  B. Smoller,et al.  Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study , 2013, Clinical, cosmetic and investigational dermatology.

[40]  M. Jamora,et al.  A comparative study of the safety and efficacy of 75% mulberry (Morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial. , 2011, Journal of drugs in dermatology : JDD.

[41]  Jean Krutmann,et al.  Airborne particle exposure and extrinsic skin aging. , 2010, The Journal of investigative dermatology.

[42]  V. Hegyi,et al.  [Methods and means for pigmentation and depigmentation. Sense or nonsense?]. , 2010, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[43]  C. Berking,et al.  [Principles of skin pigmentation. Biochemistry and regulation of melanogenesis]. , 2010, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[44]  Erica C Davis,et al.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. , 2010, The Journal of clinical and aesthetic dermatology.

[45]  S. Eimpunth,et al.  Low‐Fluence Q‐Switched Neodymium‐Doped Yttrium Aluminum Garnet (1,064 nm) Laser for the Treatment of Facial Melasma in Asians , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[46]  J. Hegyi,et al.  Methoden und Mittel zur Pigmentierung und Depigmentierung , 2010, Der Hautarzt.

[47]  C. Berking,et al.  Grundlagen der Hautpigmentierung , 2010, Der Hautarzt.

[48]  G. Mujtaba,et al.  Comparison of efficacy of topical 2% liquiritin, topical 4% liquiritin and topical 4% hydroquinone in the management of melasma , 2009 .

[49]  B. Kıvçak,et al.  Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open‐label study , 2008, The Journal of dermatology.

[50]  K. Hassun,et al.  A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma , 2007, Journal of cosmetic dermatology.

[51]  M. Jarratt.  Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. , 2004, Cutis.

[52]  Sun-Lim Choi,et al.  Aloesin inhibits hyperpigmentation induced by UV radiation , 2002, Clinical and experimental dermatology.

[53]  T. Hamilton,et al.  Topical tretinoin (retinoic acid) improves melasma. A vehicle‐controlled, clinical trial , 1993, The British journal of dermatology.